Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 89 Records) |
Query Trace: Schizophrenia and CYP2D6[original query] |
---|
Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2018 Dec 1-53. Djordjevic Natasa, Radmanovic Branimir, Cukic Jelena, Baskic Dejan, Djukic-Dejanovic Slavica, Milovanovic Dragan, Aklillu Ele |
Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report. Pharmacogenomics 2019 8 20 (12): 871-877. Sangüesa Estela, Cirujeda Christine, Concha Julia, Padilla Pedro Pablo, Ribate María Pilar, García Cristina Bel |
Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects. Therapeutic drug monitoring 2019 Aug . Miroshnichenko Igor I, Pozhidaev Ivan V, Ivanova Svetlana A, Baymeeva Natalia |
Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia. International clinical psychopharmacology 2019 3 34 (3): 124-130. Kanahara Nobuhisa, Yoshimura Kensuke, Nakamura Miwako, Oda Yasunori, Watanabe Motoki, Iyo Masao |
Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients. Irish journal of medical science 2019 Feb . Gr?dinaru Raluca, Andreescu Nicoleta, Nussbaum Laura, Suciu Liana, Puiu Mar |
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity. The pharmacogenomics journal 2019 Oct . Lesche Dorothea, Mostafa Sam, Everall Ian, Pantelis Christos, Bousman Chad |
Liver enzyme CYP2D6 gene and tardive dyskinesia. Pharmacogenomics 2020 9 21 (15): 1065-1072. Lu Justin Y, Tiwari Arun K, Freeman Natalie, Zai Gwyneth C, Luca Vincenzo de, Müller Daniel J, Tampakeras Maria, Herbert Deanna, Emmerson Heather, Cheema Sheraz Y, King Nicole, Voineskos Aristotle N, Potkin Steven G, Lieberman Jeffrey A, Meltzer Herbert Y, Remington Gary, Kennedy James L, Zai Clement |
CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People. Frontiers in pharmacology 2020 8 11 936. Cui Yuanxia, Yan Hao, Su Yi, Wang Lifang, Lu Tianlan, Zhang Dai, Yue Weih |
ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone. Progress in neuro-psychopharmacology & biological psychiatry 2020 Jul 110042. Ganoci Lana, Trkulja Vladimir, Živkovi? Maja, Božina Tamara, Šagud Marina, Lovri? Mila, Božina Na |
Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia. Archives of medical research 2020 Feb 51 (1): 13-20. Zakharyan Roksana, Ghazaryan Hovsep, Kocourkova Lenka, Chavushyan Andranik, Mkrtchyan Artur, Zizkova Veronika, Arakelyan Arsen, Petrek Mart |
Effect of Routine Cytochrome P450 2D6 and 2C19 Genotyping on Antipsychotic Drug Persistence in Patients With Schizophrenia: A Randomized Clinical Trial. JAMA network open 2020 12 3 (12): e2027909. Jürgens Gesche, Andersen Stig E, Rasmussen Henrik B, Werge Thomas, Jensen Heidi D, Kaas-Hansen Benjamin Skov, Nordentoft Mere |
Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Jan 133 111087. Zubiaur Pablo, Soria-Chacartegui Paula, Koller Dora, Navares-Gómez Marcos, Ochoa Dolores, Almenara Susana, Saiz-Rodríguez Miriam, Mejía-Abril Gina, Villapalos-García Gonzalo, Román Manuel, Martín-Vílchez Samuel, Abad-Santos Francis |
Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in pharmacology 2021 8 12 711940. Soria-Chacartegui Paula, Villapalos-García Gonzalo, Zubiaur Pablo, Abad-Santos Francisco, Koller Do |
Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone. BMC psychiatry 2021 Feb 21 (1): 70. Lu Jinjun, Yang Ye, Lu Jian, Wang Zuqing, He Yiping, Yan Yeliang, Fu Kai, Jiang Wenjuan, Xu Yunqing, Wu Renrong, Liu Wenqing, Zhao Jingpi |
Olanzapine-Associated Rhabdomyolysis: A Case Report. Cureus 2021 2 13 (1): e12568. Skryabin Valentin Y, Zastrozhin Michael, Sychev Dmitry |
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders. Molecular psychiatry 2021 11 27 (3): 1435-1447. Alkelai Anna, Greenbaum Lior, Docherty Anna R, Shabalin Andrey A, Povysil Gundula, Malakar Ayan, Hughes Daniel, Delaney Shannon L, Peabody Emma P, McNamara James, Gelfman Sahar, Baugh Evan H, Zoghbi Anthony W, Harms Matthew B, Hwang Hann-Shyan, Grossman-Jonish Anat, Aggarwal Vimla, Heinzen Erin L, Jobanputra Vaidehi, Pulver Ann E, Lerer Bernard, Goldstein David |
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 2021 Sep 13 (10): . Zubiaur Pablo, Fernández-Campos Paula, Navares-Gómez Marcos, Soria-Chacartegui Paula, Villapalos-García Gonzalo, Román Manuel, Mejía-Abril Gina, Ochoa Dolores, Abad-Santos Francis |
Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations. Progress in neuro-psychopharmacology & biological psychiatry 2021 Jan 109 110241. Ma Lingyue, Xiang Qian, Zhao Nan, Hu Changqing, Fang Meng, Tan Yunlong, Chen Song, Wang Zining, Liu Pinglan, Sun Kaoxiang, Li Youxin, Wu Fuxi, Tian Hongjun, Fang Maosheng, Zhao Xia, Wang Gang, Cui Yim |
Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia. NPJ schizophrenia 2021 Jan 7 (1): 5. Shin Wonsuk, Bang Minji, Kim Anhye, Cho Doo-Yeoun, Lee Sang-Hy |
Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions 2022 Jul 364 110042. Sangüesa Estela, Cirujeda Christine, Concha Julia, Padilla Pedro Pablo, García Cristina Belén, Ribate María Pil |
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
Translational psychiatry 2022 4 12 (1): 145. Okhuijsen-Pfeifer C, van der Horst M Z, Bousman C A, Lin B, van Eijk K R, Ripke S, Ayhan Y, Babaoglu M O, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, Edlinger M, Erdogan I M, Ertu?rul A, Yoca G, Everall I P, Görlitz T, , Grootens K P, Gutwinski S, Hallikainen T, Jeger-Land E, de Koning M, Lähteenvuo M, Legge S E, Leucht S, Morgenroth C, Müderriso?lu A, Narang A, Pantelis C, Pardiñas A F, Oviedo-Salcedo T, Schneider-Thoma J, Schreiter S, Repo-Tiihonen E, Tuppurainen H, Veereschild M, Veerman S, de Vos M, Wagner E, Cohen D, Bogers J P A M, Walters J T R, Ya?c?o?lu A E Anil, Tiihonen J, Hasan A, Luykx J |
CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations. Neuropsychiatric disease and treatment 2022 4 18 731-736. Li Yong-Hang, Huang Wei, Xiao Man-Yu, Huang Shi-Qing, Chen Hui, Li Zai-Fang, Li Xue-Song, Cheng Yo |
Antipsychotic drug-aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms. Pharmacological reports : PR 2022 12 75 (1): 19-31. Stelmach Adriana, Guzek Katarzyna, Ro?nowska Alicja, Najbar Irena, Sadakierska-Chudy An |
The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders. Drug metabolism and personalized therapy 2022 11 . Kibitov Andrey Alexandrovitch, Kiryanova Elena Mikhaylovna, Salnikova Ludmila Ivanovna, Bure Irina Vladimirovna, Shmukler Alexander Borisovitch, Kibitov Alexander Olegovit |
Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain? Journal of personalized medicine 2022 10 12 (10): . Jürgens Gesche, Kaas-Hansen Benjamin Skov, Nordentoft Merete, Werge Thomas, Andersen Stig Ejdr |
Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19. Journal of personalized medicine 2023 9 13 (9): . Amrit K Sandhu, Elnaz Naderi, Morenika J Wijninga, Edith J Liemburg, Group Investigators, Danielle Cath, Richard Bruggeman, Behrooz Z Alizad |
CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients. Scientific reports 2023 10 13 (1): 18507. Ferenc Fekete, Ádám Menus, Katalin Tóth, Ádám Ferenc Kiss, Annamária Minus, Dávid Sirok, Aleš Beli?, Ádám Póti, Gábor Csukly, Katalin Monosto |
The potential influence of estrogen-containing oral contraception on clozapine metabolism in a patient with known pharmacogenomic status. The mental health clinician 2024 6 14 (3): 220-223. Alyssa K Kuhn, Meina L Determan, Jessica A Wright, Eric Matey, Jonathan G Leu |
Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine. Heliyon 2024 4 10 (7): e28832. Ye Yang, Wenqing Liu, Renrong |
Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients. BMC psychiatry 2024 1 24 (1): 41. Xiaoyi Wang, Jing Huang, Jianjun Lu, Xuemei Li, Hui Tang, Ping Sh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 11, 2024
- Content source: